Investigation into Colombia’s President Petro by US Prosecutors in Drug-Related Cases

Gustavo Petro, the President of Colombia, is currently facing scrutiny from two U.S. federal prosecutors' offices regarding allegations connected to drug trafficking. A source with knowledge of the situation has reported that Petro is not the primary subject of these investigations.

The inquiries, conducted by U.S. Attorney’s offices located in Manhattan and Brooklyn, New York, are centered around narco-terrorism and drug trafficking. According to the source, "There are not ongoing investigations that are squarely focused on him."

These probes involve specialized prosecutors in international narcotics trafficking, as well as agents from the Drug Enforcement Administration (DEA) and Homeland Security Investigations.

Reports suggest that investigators are looking into Petro’s alleged interactions with drug traffickers, and whether his presidential campaign has received financial support tied to these networks.

The investigations are still in their preliminary stages, and it remains uncertain if they will result in any formal charges.

The Colombian presidency has yet to respond to requests for comment, and U.S. prosecutors have chosen not to offer any public statements regarding the matter.

This development occurs against a backdrop of tense relations between Petro and U.S. President Donald Trump, who has previously accused the Colombian leader of facilitating cocaine trafficking. In response, Petro has dismissed these assertions, emphasizing the historical cooperation between Colombia and the U.S., while arguing that American demand is a driving force behind the global drug trade.

Amid these strains, both leaders seemed to mitigate tensions during a meeting at the White House in February, where Trump described Petro as "terrific," and Petro called on the U.S. to concentrate on dismantling major drug trafficking organizations.

These ongoing investigations add a new layer of complexity to the diplomatic relationship between Washington and Bogotá, as authorities continue to probe the connections between political figures and global drug networks.